You are viewing a free limited preview of ZONARE Medical Systems
Get Full Access To This Report 
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
Formerly known as NovaSonics, ZONARE Medical Systems is a privately-held, venture capital backed business that engages in developing, manufacturing, and commercializing compact ultrasound systems. Founded in 1999, ZONARE Medical Systems is headquartered in Mountain View, California.
| Company Tags: | VC Backed |
| Year Founded: | 1999 |
| Formerly Named: | NovaSonics, Inc. |
| Fiscal Year End: | 12/31 |
| 1YR Revenue Growth Rate: | View % |
| 3YR Revenue Growth Rate (CAGR): | View % |
| 1YR Employee Growth Rate: | View % |
| City: | Mountain View |
| State/Province: | California |
| Country: | United States |
| Phone: | View |
| Website: | www.zonare.com |
| Healthcare > Medical Devices & Equipment > Medical Diagnostic Equipment |
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
Export All ZONARE Medical Systems Financials To Excel
$99 Single Company AccessInstant Full Site-Wide Access| Income Statement | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
| Revenues | View | View | View | View | View | View | $1,298,000 |
| Cost of Goods and Services Sold | View | View | $2,895,000 | ||||
| Gross Profit | View | View | ($1,597,000) | ||||
| Selling and Marketing Expenses | View | View | $8,836,000 | ||||
| General and Administrative Expenses | View | View | $1,798,000 | ||||
| Research and Development Expense (Excluding In - Process) | View | View | $6,807,000 | ||||
| Total Operating Expenses excluding costs | View | View | $17,441,000 | ||||
| Operating Income/(Loss) | View | View | ($19,038,000) | ||||
| Interest Expense | View | View | $143,000 | ||||
| Interest Income | View | View | $288,000 | ||||
| Non-operating Income/(Expense) - Other | View | View | $399,000 | ||||
| Minority Interest, Net of Tax Effect | View | View | ($99,000) | ||||
| Income/(Loss) Before Cumulative Effect of Change in Accounting Principle | View | View | ($18,395,000) | ||||
| Cumulative Effect of a Change in Accounting Principle, Net of Tax Effect | View | View | ($164,000) | ||||
| Net Income (Loss) | View | View | ($18,559,000) | ||||
| Other Preferred Stock Dividends and Adjustments | View | View | $1,069,000 | ||||
| Net Income Applicable to Common Stockholders | View | View | ($19,628,000) |
| Balance Sheet | 2007 | 2006 |
| Cash and Cash Equivalents | View | View |
| Short-Term Investments | View | View |
| Net Accounts Receivable Trade | View | View |
| Net Inventories | View | View |
| Other Deferred Short Term Asset Charges | View | View |
| Prepaid Expenses | View | View |
| Current Assets | View | View |
| Net Property, Plant and Equipment | View | View |
| Deferred Financing Costs | View | View |
| Other Deferred Long Term Asset Charges | View | View |
| Restricted Cash | View | View |
| Noncurrent Other Assets | View | View |
| Assets | View | View |
| Accounts Payable | View | View |
| Accrued Expenses - Other | View | View |
| Accrued Salaries | View | View |
| Current Deferred/(Unearned) Revenue | View | View |
| Current Loans Payable | View | View |
| Current Capital Lease Obligations | View | View |
| Current Liabilities | View | View |
| Loans - Long-Term | View | View |
| Capital Lease Obligations - Long-Term | View | View |
| Deferred/(Unearned) Revenue - Long-Term | View | View |
| Other Deferred Long Term Liability Charges | View | View |
| Noncurrent Warranty and Related Accruals | View | View |
| Noncurrent Other Liabilities | View | View |
| Liabilities | View | View |
| Redeemable Convertible Preferred Stock Obligations | View | View |
| Common Stock - Value (Excluding Additional Paid in Capital) | View | View |
| Additional Paid in Capital | View | View |
| Retained Earnings | View | View |
| Other Accumulated Comprehensive Income, Net of Tax Effect | View | View |
| Stockholders' Equity | View | View |
| Liabilities and Stockholders' Equity | View | View |
| Cash Flow Statement | 2007 | 2006 | 2005 |
| Operating Activities Beginning Net Income | View | View | ($18,559,000) |
| Amortization | View | View | $66,000 |
| Depreciation and Amortization | View | View | $1,246,000 |
| Total Adjustments to Provision for Doubtful Accounts | View | View | $44,000 |
| Asset Impairment Charges | View | View | $0 |
| Gain/(Loss) on Sale/Retirement of Property, Plant and Equipment | View | View | ($32,000) |
| Adjustment for Equity Based Compensation Expense | View | View | $0 |
| Adjustment Write Off of Inventory | View | View | $180,000 |
| Adjustment Derivatives | View | View | ($355,000) |
| Adjustment Minority Interest | View | View | $20,000 |
| Adjustments to Cumulative Effect of a Change in Accounting Principle, Net of Tax Effect | View | View | ($164,000) |
| Noncash Expenses - Other | View | View | $13,000 |
| Change Accounts Receivable | View | View | $2,255,000 |
| Increase/(Decrease) in Inventories | View | View | $2,795,000 |
| Change Prepaid Expenses Other Current Assets | View | View | ($323,000) |
| Increase/(Decrease) in Deferred Charges | View | View | $3,079,000 |
| Increase/(Decrease) in Other Non-operating Assets | View | View | $0 |
| Increase/(Decrease) in Accounts Payable | View | View | ($308,000) |
| Increase/(Decrease) in Accrued Expenses | View | View | $938,000 |
| Increase/(Decrease) in Unearned Premiums | View | View | $5,010,000 |
| Increase/(Decrease) in Other Non-operating Liabilities | View | View | $0 |
| Net Cash Flows Provided By/(Used In) Operating Activities | View | View | ($19,315,000) |
| Purchase of Property, Plant and Equipment | View | View | $702,000 |
| Increase Decrease Restricted Funds | View | View | $0 |
| Net Proceeds from Sale of Short-Term Investments | View | View | $11,967,000 |
| Net Purchase of Short-Term Investments | View | View | $1,732,000 |
| Increase Decrease Deposits | View | View | $0 |
| Net Cash Flows Provided By/(Used In) Investing Activities | View | View | $9,533,000 |
| Proceeds from Bank Debt | View | View | $600,000 |
| Repayments Bank Debt | View | View | $614,000 |
| Reduction of Capital Lease Obligations | View | View | $165,000 |
| Proceeds from Issuance of Redeemable Convertible Preferred Stock | View | View | $27,120,000 |
| Proceeds from Stock Options Exercised | View | View | $18,000 |
| Stock Issuance Costs | View | View | $0 |
| Net Cash Flows Provided By/(Used In) Financing Activities | View | View | $26,959,000 |
| Effect of Exchange Rate on Cash and Cash Equivalents | View | View | ($20,000) |
| Increase/(Decrease) in Cash and Cash Equivalents | View | View | $17,157,000 |
| Cash and cash equivalents at the beginning of the year | View | View | $9,810,000 |
| Total Cash and cash equivalents at the end of the year | View | View | $26,967,000 |
| Cash Interest Expense | View | View | $124,000 |
| Fair Value of Assets Acquired | View | View | $0 |
| Supplemental Other Net | View | View | $6,499,000 |
| Financial Notes: | |
| * | ZONARE Medical Systems fiscal year end: 12/31 |
Export All ZONARE Medical Systems Financials To Excel
$99 Single Company AccessInstant Full Site-Wide AccessZONARE Medical Systems Total Employees: |
ZONARE Medical Systems Productivity (Revenue/Employee) ($): |
ZONARE Medical Systems Revenues ($ MM): |
ZONARE Medical Systems Cost of Goods and Services Sold ($ MM): |
ZONARE Medical Systems Gross Profit ($ MM): |
ZONARE Medical Systems Selling and Marketing Expenses ($ MM): |
ZONARE Medical Systems General and Administrative Expenses ($ MM): |
ZONARE Medical Systems Research and Development Expense (Excluding In - Process) ($ MM): |
ZONARE Medical Systems Total Operating Expenses excluding costs ($ MM): |
ZONARE Medical Systems Operating Income/(Loss) ($ MM): |
ZONARE Medical Systems Interest Expense ($): |
ZONARE Medical Systems Interest Income ($): |
ZONARE Medical Systems Non-operating Income/(Expense) - Other ($ MM): |
ZONARE Medical Systems Minority Interest, Net of Tax Effect ($): |
ZONARE Medical Systems Income/(Loss) Before Cumulative Effect of Change in Accounting Principle ($ MM): |
ZONARE Medical Systems Cumulative Effect of a Change in Accounting Principle, Net of Tax Effect ($): |
ZONARE Medical Systems Net Income (Loss) ($ MM): |
ZONARE Medical Systems Other Preferred Stock Dividends and Adjustments ($ MM): |
ZONARE Medical Systems Net Income Applicable to Common Stockholders ($ MM): |
ZONARE Medical Systems Cash and Cash Equivalents ($ MM): |
ZONARE Medical Systems Short-Term Investments ($ MM): |
ZONARE Medical Systems Net Accounts Receivable Trade ($ MM): |
ZONARE Medical Systems Net Inventories ($ MM): |
ZONARE Medical Systems Other Deferred Short Term Asset Charges ($ MM): |
ZONARE Medical Systems Prepaid Expenses ($ MM): |
ZONARE Medical Systems Current Assets ($ MM): |
ZONARE Medical Systems Net Property, Plant and Equipment ($ MM): |
ZONARE Medical Systems Deferred Financing Costs ($ MM): |
ZONARE Medical Systems Other Deferred Long Term Asset Charges ($ MM): |
ZONARE Medical Systems Restricted Cash ($ MM): |
ZONARE Medical Systems Noncurrent Other Assets ($): |
ZONARE Medical Systems Assets ($ MM): |
ZONARE Medical Systems Accounts Payable ($ MM): |
ZONARE Medical Systems Accrued Expenses - Other ($ MM): |
ZONARE Medical Systems Accrued Salaries ($ MM): |
ZONARE Medical Systems Current Deferred/(Unearned) Revenue ($ MM): |
ZONARE Medical Systems Current Loans Payable ($): |
ZONARE Medical Systems Current Capital Lease Obligations ($): |
ZONARE Medical Systems Current Liabilities ($ MM): |
ZONARE Medical Systems Loans - Long-Term ($ MM): |
ZONARE Medical Systems Capital Lease Obligations - Long-Term ($): |
ZONARE Medical Systems Deferred/(Unearned) Revenue - Long-Term ($ MM): |
ZONARE Medical Systems Other Deferred Long Term Liability Charges ($): |
ZONARE Medical Systems Noncurrent Warranty and Related Accruals ($ MM): |
ZONARE Medical Systems Liabilities ($ MM): |
ZONARE Medical Systems Redeemable Convertible Preferred Stock Obligations ($ MM): |
ZONARE Medical Systems Common Stock - Value (Excluding Additional Paid in Capital) ($): |
ZONARE Medical Systems Additional Paid in Capital ($ MM): |
ZONARE Medical Systems Retained Earnings ($ MM): |
ZONARE Medical Systems Other Accumulated Comprehensive Income, Net of Tax Effect ($): |
ZONARE Medical Systems Stockholders' Equity ($ MM): |
ZONARE Medical Systems Liabilities and Stockholders' Equity ($ MM): |
ZONARE Medical Systems Operating Activities Beginning Net Income ($ MM): |
ZONARE Medical Systems Amortization ($): |
ZONARE Medical Systems Depreciation and Amortization ($ MM): |
ZONARE Medical Systems Total Adjustments to Provision for Doubtful Accounts ($): |
ZONARE Medical Systems Asset Impairment Charges ($): |
ZONARE Medical Systems Gain/(Loss) on Sale/Retirement of Property, Plant and Equipment ($): |
ZONARE Medical Systems Adjustment for Equity Based Compensation Expense ($): |
ZONARE Medical Systems Adjustment Write Off of Inventory ($): |
ZONARE Medical Systems Adjustment Derivatives ($ MM): |
ZONARE Medical Systems Adjustment Minority Interest ($): |
ZONARE Medical Systems Adjustments to Cumulative Effect of a Change in Accounting Principle, Net of Tax Effect ($): |
ZONARE Medical Systems Noncash Expenses - Other ($): |
ZONARE Medical Systems Change Accounts Receivable ($ MM): |
ZONARE Medical Systems Increase/(Decrease) in Inventories ($ MM): |
ZONARE Medical Systems Change Prepaid Expenses Other Current Assets ($): |
ZONARE Medical Systems Increase/(Decrease) in Deferred Charges ($ MM): |
ZONARE Medical Systems Increase/(Decrease) in Other Non-operating Assets ($): |
ZONARE Medical Systems Increase/(Decrease) in Accounts Payable ($ MM): |
ZONARE Medical Systems Increase/(Decrease) in Accrued Expenses ($ MM): |
ZONARE Medical Systems Increase/(Decrease) in Unearned Premiums ($ MM): |
ZONARE Medical Systems Net Cash Flows Provided By/(Used In) Operating Activities ($ MM): |
ZONARE Medical Systems Purchase of Property, Plant and Equipment ($ MM): |
ZONARE Medical Systems Increase Decrease Restricted Funds ($ MM): |
ZONARE Medical Systems Net Proceeds from Sale of Short-Term Investments ($ MM): |
ZONARE Medical Systems Net Purchase of Short-Term Investments ($ MM): |
ZONARE Medical Systems Increase Decrease Deposits ($): |
ZONARE Medical Systems Net Cash Flows Provided By/(Used In) Investing Activities ($ MM): |
ZONARE Medical Systems Proceeds from Bank Debt ($ MM): |
ZONARE Medical Systems Repayments Bank Debt ($ MM): |
ZONARE Medical Systems Reduction of Capital Lease Obligations ($): |
ZONARE Medical Systems Proceeds from Issuance of Redeemable Convertible Preferred Stock ($ MM): |
ZONARE Medical Systems Proceeds from Stock Options Exercised ($): |
ZONARE Medical Systems Stock Issuance Costs ($): |
ZONARE Medical Systems Net Cash Flows Provided By/(Used In) Financing Activities ($ MM): |
ZONARE Medical Systems Effect of Exchange Rate on Cash and Cash Equivalents ($): |
ZONARE Medical Systems Increase/(Decrease) in Cash and Cash Equivalents ($ MM): |
ZONARE Medical Systems Cash and cash equivalents at the beginning of the year ($ MM): |
ZONARE Medical Systems Total Cash and cash equivalents at the end of the year ($ MM): |
ZONARE Medical Systems Cash Interest Expense ($): |
ZONARE Medical Systems Fair Value of Assets Acquired ($): |
ZONARE Medical Systems Supplemental Other Net ($ MM): |
Export Financials to Excel
$99 Single Company AccessInstant Full Site-Wide AccessMissing a deal? Tell us about it! tips@privco.com
|
Get Full Access To This Report
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
PrivCo is the authority for financial & business data on major private companies, including:
| Private Companies | 209,177 |
| Private Investors | 12,027 |
| Private M&A Deals | 43,194 |
| VC/Funding Rounds | 36,112 |
| Total Data Points | 95,786,176 |
You are viewing a free limited preview of ZONARE Medical Systems
PrivCo is the premier source for business and financial data on major, non-publicly traded corporations, including family owned, private equity owned, venture backed, and international unlisted companies. Click here to learn more.
PDF VERSION: Download Company Report in PDF Format
Full Online Report
